Skip Navigation



ToxSci Advance Access published online on March 6, 2009

Toxicological Sciences, doi:10.1093/toxsci/kfp050
This Article
Right arrow Advance Access manuscript (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
109/2/193    most recent
kfp050v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Phillips, J. M.
Right arrow Articles by Goodman, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phillips, J. M.
Right arrow Articles by Goodman, J. I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

Phenobarbital (PB) Elicits Unique, Early Changes in the Expression of Hepatic Genes That Affect Critical Pathways in Tumor-Prone B6C3F1 Mice

Jennifer M. Phillips*, Lyle D. Burgoon*,{dagger} and Jay I. Goodman{ddagger},1

* Department of Biochemistry and Molecular Biology {dagger} Gene Expression in Development and Disease Initiative {ddagger} Department of Pharmacology and Toxicology, and Center for Integrative Toxicology, Michigan State University, East Lansing, Michigan 48824

1 Corresponding Author: Jay I. Goodman, Michigan State University, B-440 Life Sciences Bldg., East Lansing, MI 48824, Email: goodman3{at}msu.edu, Tel: 517-353-9346, Fax: 517-353-8915

Received January 12, 2009; revision received February 18, 2009; accepted March 3, 2009


   Abstract

At 2 and 4 weeks following treatment with Phenobarbital (PB), the classical nongenotoxic rodent liver carcinogen, we elucidated unique gene expression changes (both induction and repression) in liver tumor-susceptible B6C3F1 mice, as compared to the relatively resistant C57BL/6. Based on their cancer-related roles, we believe that altered expression of at least some of these genes might underlie PB-induced liver tumorigenesis. Putative constitutive active/androstane (CAR) response elements (CAREs), a subset of PB response elements, were present within multiple genes whose expression was uniquely altered in the B6C3F1 mice, suggesting a role for CAR in their regulation. Additionally, 3 DNA methyltransferase genes (Dnmt1, Dnmt3a, and Dnmt3b) were repressed uniquely in the tumor-prone B6C3F1 mice, and all possess putative CAREs, providing a potential direct link between PB and expression of key genes that regulate DNA methylation status.

Previously, we demonstrated that PB elicited unique regions of altered methylation (RAMs) in B6C3F1 mice, as compared to the relatively resistant C57BL/6, at 2 and 4 weeks (Bachman et al., 2006), and annotation of the regions harboring these changes revealed 51 genes (Phillips and Goodman, 2008a). This is extended by the current study, which employed RNA isolated from the same liver tissue used in the earlier investigations. Genes elucidated from both the methylation and expression analyses are involved in identical processes/pathways (e.g., cell cycle, apoptosis, angiogenesis, epithelial-mesenchymal cell transition (EMT), invasion/metastasis, and mitogen-activated protein kinase (MAPK), transforming growth factor-beta (TGF-β), and Wingless (Wnt) signaling). Therefore, these changes might represent very early events that directly contribute to PB-induced tumorigenesis. It is instructive to consider the possibility that, in a hypothesis-driven fashion, these genes are initial candidates that could be utilized to develop a biomarker "fingerprint" of early exposure to PB and PB-like compounds.

Key Words: B6C3F1; CAR; gene expression; mouse liver; phenobarbital; tumors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
J. M. Phillips, L. D. Burgoon, and J. I. Goodman
The Constitutive Active/Androstane Receptor Facilitates Unique Phenobarbital-Induced Expression Changes of Genes Involved in Key Pathways in Precancerous Liver and Liver Tumors
Toxicol. Sci., August 1, 2009; 110(2): 319 - 333.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.